July 10, 2015 -Â Opsens Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the OptoWire ...
FFR Technologies
This channel includes news and new technology innovations for fractional flow reserve (FFR) wires, catheters and systems used to measure blood flow across a coronary lesion to determine if a stent is needed or if the plaque stenosis can be treated medically. The section includes iFR, instantaneous wave-free ratio, systems used in the cath lab and noninvasive FFR technologies including computed tomography-FFR. This is also referred to as CT-FFR or FFR-CT.
Key to ongoing U.S. healthcare reform are efforts to reduce costs by eliminating unnecessary medical procedures and ...
May 22, 2015 — St. Jude Medical Inc. announced new results from two clinical studies further supporting the use of its f ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 20, 2015 — Adding the HeartFlow FFRCT Analysis to a standard coronary computed tomography angiogram (cCTA) may ...
April 6, 2015 — Royal Philips announced that Volcano, a Philips business, has received CE Mark for the iFR Scout ...
As an early adopter of fractional flow reserve (FFR) for the diagnosis of ischemia, my initial decision to transition ...
February 5, 2015 — A new computer program allows doctors to assess blood flow as they are using flow-diverter devices to ...
January 14, 2015 — Opsens Inc. announced the first use of its Fractional Flow Reserve (FFR) products in Europe by the ...
January 7, 2015 — Volcano Corp. announced that more than 1,000 systems have been activated with its instant wave-Free ...
Earlier this year, the Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis adopted the ...
John Stevens, chairman and CEO of HeartFlow, explains his company's computed tomography (CT)-based fractional flow ...
September 18, 2014 — A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting ...
September 15, 2014 — St. Jude Medical Inc. announced primary outcome two-year data from the FAME 2 clinical trial, which ...
September 12, 2014 — Volcano Corp. announced it will be launching its interventional precision guidance tools at the ...